Perfil
Ira Weisberg is currently President-Medical Division at Endonovo Therapeutics, Inc. since 2022.
Former positions include President & Chief Executive Officer at AlphaVax, Inc., Amherst Pharmaceuticals LLC, and SofPulse, Inc.; Senior Director-Business Development at Aventis Behring; Senior Vice President-Commercial Operations at Neurotrope, Inc.; Vice President-Commercial Operations at TAO Synergies, Inc.; and Vice President-Operations at Haemacure Corp.
(Florida).
Education includes undergraduate studies at St. John's University.
Cargos activos de Ira Weisberg
| Empresas | Cargo | Inicio |
|---|---|---|
| ENDONOVO THERAPEUTICS, INC. | Corporate Officer/Principal | 30/11/2022 |
Antiguos cargos conocidos de Ira Weisberg.
| Empresas | Cargo | Fin |
|---|---|---|
Aventis Behring
Aventis Behring Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Corporate Officer/Principal | 29/11/2011 |
Haemacure Corp. (Florida) | Director de Operaciones | - |
Amherst Pharmaceuticals LLC
Amherst Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director Ejecutivo | - |
Sofpulse, Inc.
Sofpulse, Inc. Medical SpecialtiesHealth Technology Develops and commercializes medical devices | Director Ejecutivo | - |
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology Developing a new vaccine technology with broad applications against infectious diseases | Director Ejecutivo | - |
Formación de Ira Weisberg.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 9 |
|---|---|
Neurotrope, Inc.
Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurodegenerative diseases | Health Technology |
Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops off the shelf regenerative products that no longer require the injection of stem cells | Health Technology |
Aventis Behring
Aventis Behring Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Health Technology |
St. John's University
St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology Developing a new vaccine technology with broad applications against infectious diseases | Health Technology |
Haemacure Corp. (Florida) | |
Synaptogenix, Inc.
Synaptogenix, Inc. Packaged SoftwareTechnology Services Develops decentralized blockchain network that focuses on convergence between cryptocurrency and artificial intelligence | Technology Services |
Amherst Pharmaceuticals LLC
Amherst Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sofpulse, Inc.
Sofpulse, Inc. Medical SpecialtiesHealth Technology Develops and commercializes medical devices | Health Technology |
- Bolsa de valores
- Insiders
- Ira Weisberg
















